| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $33.48M | $25.81M | $12.86M | $13.41M | $23.06M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$165.85M | $664.63M | $392.95M | -$666.38M | $416.79M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |